Evidence that TET2 and IDH1/2 mutations are mutually exclusive in AML tumours [79] supports the notion that TETs inhibition and the ensuing DNA hypermethylation are instrumental to IDH-driven tumorigenesis. The gene discussed is IDH2; the disease is neoplasm.